Sex-Steroid Imbalance in Females and Dry Eye

References

• Stern ME, Gao J, Siemasko KF, Beuerman RW, Pflugfelder SC. The role of the lachrymal functional unit in the pathophysiology of dry eye. Exp Eye Res 2004;78:409–416
   PubMed Web of Science ®Google Scholar
• Gipson IK. The ocular surface: the challenge to enable and protect vision. The Friedenwald Lecture. Invest Ophthalmol Vis Sci 2007;48:4391–4398
   Web of Science ®Google Scholar
• Lemp MA. Advances in understanding and managing dry eye disease. Am J Ophthalmol 2008;146:350–356
   PubMed Web of Science ®Google Scholar
• The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop. Ocul Surf 2007;5:75–92
   Google Scholar
• Nichols KK, Nichols JJ, Mitchell GL. The lack of association between signs and symptoms in patients with dry eye disease. Cornea 2004;23:762–770
   PubMed Web of Science ®Google Scholar
• Pult H, Purslow C, Murphy PJ. The relationship between clinical signs and dry eye symptoms. Eye 2011;25:502–510
   PubMed Web of Science ®Google Scholar
• Schein OD, Tielsch JM, Munoz B, Baqndeen-Roche K, West S. Relation between signs and symptoms of dry eye in the elderly. A population-based perspective. Ophthalmology 1997;104:1395–1401
   PubMed Web of Science ®Google Scholar
• Korb DR. Survey of preferred tests for diagnosis of the tear film and dry eye. Cornea 2000;19:483–486
   PubMed Web of Science ®Google Scholar
• Nichols KK, Nichols JJ, Zadnik K. Frequency of dry eye diagnostic test procedures used in various modes of ophthalmic practice. Cornea 2000;19:477–482
   PubMed Web of Science ®Google Scholar
• Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop. Ocul Surf 2007;5:108–152
   Google Scholar
• Report of the Research Subcommittee of the International Dry Eye Workshop. Ocul Surf 2007;5:179--195
   Google Scholar
• Bron AJ, Yokoi N, Gafney E, Tiffany JM. Predicted phenotypes of dry eye: proposed consequences of its natural history. Ocul Surf 2009;7:78–92
   PubMed Web of Science ®Google Scholar
• The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop. Ocul Surf 2007;5:93–107
   Google Scholar
• Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol 2003;136:318–326
   PubMed Web of Science ®Google Scholar
• Krenzer KL, Dana MR, Ullman MD, Cermak JM, Tolls DB, Evans JE, et al. Effect of androgen deficiency on the human meibomian gland and ocular surface. J Clin Endocrinol Metab 2000;85:4874–4882
   PubMed Web of Science ®Google Scholar
• Schaumberg DA, Buring JE, Sullivan DA, Dana MR. Hormone replacement therapy and dry eye syndrome. JAMA 2001;286:2114–2119
   PubMed Web of Science ®Google Scholar
• Uncu G, Avci R, Uncu Y, Kaymaz C, Develioglu O. The effects of different hormone replacement therapy regimens on tear function, intraocular pressure and lens opacity. Gynecol Endocrinol 2006;22:501–550
   PubMed Web of Science ®Google Scholar
• Smith JA, Vitale S, Reed GF, Grieshaber SA, Goodman LA, Vanderhoof VH, et al. Dry eye signs and symptoms in women with premature ovarian failure. Arch Ophthalmol 2004;122:151–156
   PubMed Web of Science ®Google Scholar
• Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 2005;90:3847–3853
   PubMed Web of Science ®Google Scholar
• Strauss JF, Barbieri RL. Yen and Jaffe’s reproductive endocrinology. 5th ed. Philadelpha, PA: Elsevier; 2004. pp 633–668
   Google Scholar
• Miller WL, Auchus RJ. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev 2011;32:81–151
   PubMed Web of Science ®Google Scholar
• Stocco DM. StAR protein and the regulation of steroid hormone biosynthesis. Annu Rev Physiol 2001;63:193–213
   PubMed Web of Science ®Google Scholar
• Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004;89:2548–2556
   PubMed Web of Science ®Google Scholar
• Luu-The V. Assessment of steroidogenesis and steroidogenic enzyme functions. J Steroid Biochem Mol Biol 2013;137:176–182
   PubMed Web of Science ®Google Scholar
• Pietras RJ, Szego CM. Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells. Nature 1977;265:69–72
   PubMed Web of Science ®Google Scholar
• Tuohimaa P, Bläuer M, Pasanen S, Passinen S, Pekki A, Punnonen R, et al. Mechanisms of action of sex steroid hormones: basic concepts and clinical correlations. Maturitas 1996;23:S3–S12
   Google Scholar
• Deroo BJ, Korach KS. Estrogen receptors and human disease. J Clin Invest 2006;116:561–570
   PubMed Web of Science ®Google Scholar
• Prossnitz ER, Barton M. The G-protein-coupled estrogen receptor GPER in health and disease. Nat Rev Endocrinol 2011;7:715–726
   PubMed Web of Science ®Google Scholar
• Labrie F. Adrenal androgens and intracrinology. Semin Reprod Med 2004;22:299–309
   PubMed Web of Science ®Google Scholar
• Luu-The V, Labrie F. The intracrine sex steroid biosynthesis pathways. Prog Brain Res 2010;181:177–192
   PubMed Web of Science ®Google Scholar
• Koos RD. Minireview: putting physiology back into estrogens' mechanism of action. Endocrinology 2011;152:4481–4488
   PubMed Web of Science ®Google Scholar
• Kaore SN, Langade DK, Yadav VK, Sharma P, Thawani VR, Sharma R. Novel actions of progesterone: what we know today and what will be the scenario in the future? J Pharm Pharmacol 2012;64:1040–1062
   PubMed Web of Science ®Google Scholar
• Mani SK, Blaustein JD, O’Malley BW. Progesterone receptor function from a behavioral perspective. Horm Behav 1977;31:244–255
   Google Scholar
• Simoncini T, Genazzani A. Non-genomic actions of sex steroid hormones. Eur J of Endocrinol 2003;148:281–292
   PubMed Web of Science ®Google Scholar
• Gruber DM, Huber JC. Gender-specific medicine: the new profile of gynecology. Gynecol Endocrinol 1999;13:1–6
   Google Scholar
• Manolagas SC, Kousteni S, Jilka RL. Sex steroids and bone. Recent Prog Horm Res 2002;57:385–409
   PubMedGoogle Scholar
• Vest RS, Pike CJ. Gender, sex steroid hormones, and Alzheimer's disease. Horm Behav 2013;63:301–307
   PubMed Web of Science ®Google Scholar
• Lovejoy JC. The influence of sex hormones on obesity across the female life span. J Womens Health 1998;7:1247–1256
   PubMed Web of Science ®Google Scholar
• Traish AM, Kypreos KE. Testosterone and cardiovascular disease: an old idea with modern clinical implications. Atherosclerosis 2011;214:244–248
   PubMed Web of Science ®Google Scholar
• Sullivan DA. Tearful relationships? Sex, hormones, the lachrymal gland, and aqueous-deficient dry eye. Ocul Surf 2004;2:92–123
   PubMedGoogle Scholar
• Doughty MJ. Goblet cells of the normal human bulbar conjunctiva and their assessment by impression cytology sampling. Ocul Surf 2012;10:149–169
   PubMed Web of Science ®Google Scholar
• Versura P, Fresina M, Campos EC. Ocular surface changes over the menstrual cycle in women with and without dry eye. Gynecol Endocrinol 2007;23:385–390
   PubMed Web of Science ®Google Scholar
• Connor CG, Flockencier LL, Hall CW. The influence of gender on the ocular surface. J Am Optom Assoc 1999;70:182–186
   PubMedGoogle Scholar
• Vavilis D, Maloutas S, Nasioutziki M, Boni E, Bontis J. Conjunctiva is an estrogen-sensitive epithelium. Acta Obstet Gynecol Scand 1995;74:799–802
   Web of Science ®Google Scholar
• Kramer P, Lubkin V, Potter W, Jacobs M, Labay G, Silverman P. Cyclic changes in conjunctival smears from menstruating females. Ophthalmology 1990;97:303–307
   PubMed Web of Science ®Google Scholar
• Cavdar E, Ozkaya A, Alkin Z, Ozkaya HM, Babayigit MA. Changes in tear film, corneal topography, and refractive status in premenopausal women during menstrual cycle. Cont Lens Anterior Eye 2014;37:209--212
   Google Scholar
• Serrander AM, Peek KE. Changes in contact lens comfort related to the menstrual cycle and menopause. A review of articles. J Am Optom Assoc 1993;64:162–166
   PubMedGoogle Scholar
• Tomlinson A, Pearce EI, Simmons PA, Blades K. Effect of oral contraceptives on tear physiology. Ophthalmic Physiol Opt 2001;21:9–16
   PubMed Web of Science ®Google Scholar
• Chen SP, Massaro-Giordano G, Pistilli M, Schreiber CA, Bunya VY. Tear osmolarity and dry eye symptoms in women using oral contraception and contact lenses. Cornea 2013;32:423–428
   PubMed Web of Science ®Google Scholar
• Tatlipinar S, Gedik S, Irkeç M, Orhan M, Erdener U. Ocular ferning during the menstrual cycle in healthy women. Eur J Ophthalmol 2001;11:15–18
   Web of Science ®Google Scholar
• Nelson LM, Covington SN, Rebar RW. An update: spontaneous premature ovarian failure is not an early menopause. Fertil Steril 2005;83:1327–1332
   PubMed Web of Science ®Google Scholar
• Schechter JE, Pidgeon M, Chang D, Fong YC, Trousdale MD, Chang N. Potential role of disrupted lachrymal acinar cells in dry eye during pregnancy. Adv Exp Med Biol 2002;506:153–157
   Google Scholar
• Huang J, Lu M, Ding C. Na(+)/K(+)-ATPase expression changes in the rabbit lachrymal glands during pregnancy. Curr Eye Res 2013;38:18–26
   Web of Science ®Google Scholar
• Ding C, Lu M, Huang J. Changes of the ocular surface and aquaporins in the lachrymal glands of rabbits during pregnancy. Mol Vis 2011;17:2847–2855
   PubMed Web of Science ®Google Scholar
• Sullivan DA. Hormonal influence on the secretory immune system of the eye. In: Freir S, editor. The neuroendocrine-immune network. Boca Raton, FL: CCR Press; 1990. pp 199–237
   Google Scholar
• Sullivan DA, Jensen RV, Suzuki T, Richards SM. Do sex steroids exert sex-specific and/or opposite effects on gene expression in lachrymal and meibomian glands? Mol Vis 2009;10:1553–1572
   Google Scholar
• Fuchsjager-Mayrl G, Nepp J, Schneeberger C, Sator M, Dietrich W, Wedrich A, et al. Identification of oestrogen and progesterone receptor mRNA expression in the conjunctiva of premenopausal women. Invest Ophthalmol Vis Sci 2002;43:2841–2844
   PubMed Web of Science ®Google Scholar
• Vecsei PV, Kircher K, Kaminski S, Nagel G, Breitenecker G, Kohlberger PD. Immunohistochemical detection of oestrogen and progesterone receptor in human cornea. Maturitas 2000;31:169–172
   Google Scholar
• Esmaeli B, Harvey JT, Hewlett B. Immunohistochemical evidence for oestrogen receptors in meibomian glands. Ophthalmology 2000;107:180–184
   PubMed Web of Science ®Google Scholar
• Auw-Haedrich C, Feltgen N. Estrogen receptor expression in meibomian glands and its correlation with age and dry-eye parameters. Graefes Arch Clin Exp Ophthalmol 2003;241:705–709
   PubMed Web of Science ®Google Scholar
• Gans LA, Lee SF, Lemp MA, Pepose JS. Oestrogen and progesterone receptors and human conjunctiva. Am J Ophthalmol 1990;15:474–477
   Google Scholar
• Suzuki T, Kinoshita Y, Tachibana M, Matsushima Y, Kobayashi Y, Adachi W, et al. Expression of sex steroid hormone receptors in human cornea. Curr Eye Res 2001;22:28–33
   PubMed Web of Science ®Google Scholar
• Wied GL, Bibbo M. Hormonal cytology. In: Bibbo M, editor. Comprehensive cytopathology. Philadelphia, PA: WB Saunders Co; 1991. pp 85–114
   Google Scholar
• Rocha EM, Wickham LA, da Silveira LA, Krenzer KL, Yu FS, Toda I, et al. Identification of androgen receptor protein and 5 alpha-reductase mRNA in human ocular tissues. Br J Ophthalmol 2000; 84:76–84
   PubMed Web of Science ®Google Scholar
• Gao J, Lambert RW, Wickham LA, Sullivan DA. Androgen regulation of secretory component mRNA levels in the rat lachrymal gland. Lachrymal gland, tear film, and dry eye syndromes. Adv Exp Med Biol 1994;350:219–224
   Google Scholar
• Sullivan DA, Sullivan BD, Evans JE, Schirra F, Yamagami H, Liu M, et al. Androgen deficiency, Meibomian gland dysfunction, and evaporative dry eye. Ann N Y Acad Sci 2002;966:211–222
   PubMed Web of Science ®Google Scholar
• Sullivan DA, Allansmith MR. Hormonal modulation of tear volume in the rat. Exp Eye Res 1986;42:131–139
   PubMed Web of Science ®Google Scholar
• Beauregard C, Brandt P. Down regulation of interleukin-1 beta-induced nitric oxide production in lachrymal gland acinar cells by sex steroids. Curr Eye Res 2004;29:59–66
   PubMed Web of Science ®Google Scholar
• Wickham LA, Gao J, Toda I, Rocha EM, Ono M, Sullivan DA. Identification of androgen, estrogen and progesterone receptor mRNAs in the eye. Acta Ophthalmol Scand 2000;78:146–153
   PubMedGoogle Scholar
• Knop E, Knop N, Millar T, Obata H, Sullivan DA. The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland. Invest Ophthalmol Vis Sci 2011;52:1938–1978
   PubMed Web of Science ®Google Scholar
• Suzuki T, Sullivan DA. Estrogen stimulation of proinflammatory cytokine and matrix metalloproteinase gene expression in human corneal epithelial cells. Cornea 2005;24:1004–1009
   Web of Science ®Google Scholar
• Suzuki T, Sullivan DA. Comparative effects of estrogen on matrix metalloproteinases and cytokines in immortalized and primary human corneal epithelial cell cultures. Cornea 2006;25:454–459
   PubMed Web of Science ®Google Scholar
• Zylberberg C, Seamon V, Ponomareva O, Vellala K, Deighan M, Azzarolo AM. Estrogen up-regulation of metalloproteinase-2 and -9 expression in rabbit lachrymal glands. Exp Eye Res 2007;84:960–972
   Web of Science ®Google Scholar
• Wang C, Shi X, Chen X, Wu H, Zhang H, Xie J, et al. 17-β-estradiol inhibits hyperosmolarity-induced proinflammatory cytokine elevation via the p38 MAPK pathway in human corneal epithelial cells. Mol Vis 2012;18:1115–1122
   PubMed Web of Science ®Google Scholar
• Arakaki R, Ishimaru N, Hayashi Y. Immunotherapeutic targets in estrogen deficiency-dependent Sjögren's syndrome-related manifestations. Immunotherapy 2010;2:339–346
   Google Scholar
• Cripps MM, Bromberg BB, Welch MH. Gender-dependent lachrymal protein secretion (ARVO abstract). Invest Ophthalmol Vis Sci 1986;27:25
   Google Scholar
• Sullivan DA, Kelleher RS, Vaerman JP, Hann LE. Androgen regulation of secretory component synthesis by lachrymal gland acinar cells in vitro. J Immunol 1990;145:4238–4244
   Web of Science ®Google Scholar
• Sullivan DA, Krenzer KL, Sullivan BD, Tolls DB, Toda I, Dana MR. Does androgen insufficiency cause lachrymal gland inflammation and aqueous tear deficiency? Invest Ophthalmol Vis Sci 1999;40:1261–1265
   PubMed Web of Science ®Google Scholar
• Cermak JM, Krenzer KL, Sullivan RM, Dana MR, Sullivan DA. Is incomplete androgen insensitivity syndrome associated with alterations in the meibomian gland and ocular surface? Cornea 2003;22:516–521
   PubMed Web of Science ®Google Scholar
• Mantelli F, Moretti C, Micera A, Bonini S. Conjunctival mucin deficiency in complete androgen insensitivity syndrome (CAIS). Graefes Arch Clin Exp Ophthalmol 2007;245:899–902
   Web of Science ®Google Scholar
• Khandelwal P, Liu S, Sullivan DA. Androgen regulation of gene expression in human meibomian gland and conjunctival epithelial cells. Mol Vis 2012;18:1055–1067
   PubMed Web of Science ®Google Scholar
• Crow JM, Nelson JD, Remington SG. Human lipocalin-1 association with 3H-testosterone and 3H-estradiol. Curr Eye Res 2009;34:1042–1049
   Web of Science ®Google Scholar
• Labrie F. Extragonadal synthesis of sex steroids: intracrinology. Ann Endocrinol (Paris) 2003;64:95–107
   PubMed Web of Science ®Google Scholar
• Labrie F, Bélanger A, Luu-The V, Labrie C, Simard J, Cusan L, et al. DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging. Steroids 1998;63:322–328
   PubMed Web of Science ®Google Scholar
• Labrie F, Labrie C. DHEA and intracrinology at menopause, a positive choice for evolution of the human species. Climateric 2013;16:205–213
   PubMed Web of Science ®Google Scholar
• Schirra F, Suzuki T, Dickinson DP, Townsend DJ, Gipson IK, Sullivan DA. Identification of steroidogenic enzyme mRNAs in the human lachrymal gland, meibomian gland, cornea, and conjunctiva. Cornea 2006;25:438–442
   PubMed Web of Science ®Google Scholar
• Sullivan DA, Wickham LA, Rocha EM, Kelleher RS, da Silveira L, Toda I. Influence of gender, sex steroid hormones and the hypothalamic-pituitary axis on the structure and function of the lachrymal gland. Adv Exp Med Biol 1998;438:11–42
   PubMed Web of Science ®Google Scholar
• Waterhouse JP. Focal adenitis in salivary and lachrymal glands. Proc R Soc Med 1963;56:911–918
   PubMedGoogle Scholar
• Sullivan DA, Allansmith MR. The effect of aging on the secretory immune system of the eye. Immunology 1988;63:403–410
   PubMed Web of Science ®Google Scholar
• Craig JP, Tomlinson A. Age and gender effects on the normal tear film. Adv Exp Med Biol 1998;438:411–415
   PubMedGoogle Scholar
• Nava A, Barton K, Monroy DC, Pflugfelder SC. The effects of age, gender, and fluid dynamics on the concentration of tear film epidermal growth factor. Cornea 1997;16:430–438
   PubMed Web of Science ®Google Scholar
• Tamboli DA, Harris MA, Hogg JP, Realini T, Sivak-Callcott JA. Computed tomography dimensions of the lachrymal gland in normal Caucasian orbits. Ophthal Plast Reconstr Surg 2011;27:453–456
   Google Scholar
• Sullivan DA. Sex hormones and Sjögren's syndrome. J Rheumatol Suppl 1997;50:17–32
   PubMedGoogle Scholar
• Brennan MT, Sankar V, Leakan RA, Grisius MM, Collins MT, Fox PC, et al. Sex steroid hormones in primary Sjögren's syndrome. J Rheumatol 2003;30:1267–1271
   PubMedGoogle Scholar
• Porola P, Laine M, Virkki L, Poduval P, Konttinen YT. The influence of sex steroids on Sjögren's syndrome. Ann N Y Acad Sci 2007;1108:426–432
   PubMed Web of Science ®Google Scholar
• Konttinen YT, Fuellen G, Bing Y, Porola P, Stegaev V, Trokovic N, et al. Sex steroids in Sjögren's syndrome. J Autoimmun 2012;39:49–56
   PubMed Web of Science ®Google Scholar
• Mavragani CP, Fragoulis GE, Moutsopoulos HM. Endocrine alterations in primary Sjogren's syndrome: an overview. J Autoimmun 2012;39:354–358
   Google Scholar
• Mostafa S, Seamon V, Azzarolo AM. Influence of sex hormones and genetic predisposition in Sjögren's syndrome: a new clue to the immunopathogenesis of dry eye disease. Exp Eye Res 2012;96:88–97
   PubMed Web of Science ®Google Scholar
• Valtysdóttir ST, Wide L, Hällgren R. Low serum dehydroepiandrosterone sulfate in women with primary Sjogren’s syndrome as an isolated sign of impaired HPA axis function. J Rheumatol 2001;28:1259–1265
   PubMed Web of Science ®Google Scholar
• Sullivan DA, Bélanger A, Cermak JM, Bérubé R, Papas AS, Sullivan RM, et al. Are women with Sjogren’s syndrome androgen-deficient? J Rheumatol 2003;30:2413–2419
   PubMed Web of Science ®Google Scholar
• Laine M, Porola P, Udby L, Kjeldsen L, Cowland JB, Borregaard N. Low salivary dehydroepiandrosterone and androgen-regulated cysteine-rich secretory protein 3 levels in Sjogren’s syndrome. Arthritis Rheum 2007;56:2575–2584
   PubMed Web of Science ®Google Scholar
• Labrie F, Belanger A, Cusan L, Gomez JL, Candas B. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab 1997;82:2396–2402
   PubMed Web of Science ®Google Scholar
• Dessein PH, Joffe BI, Stanwix AE, Moomal Z. Hyposecretion of the adrenal androgen dehydroepiandrosterone sulfate and its relation to clinical variables in inflammatory arthritis. Arthritis Res 2001;3:183–188
   Google Scholar
• Labrie F, Bélanger A, Bélanger P, Bérubé R, Martel C, Cusan L, et al. Metabolism of DHEA in postmenopausal women following percutaneous administration. J Steroid Biochem Mol Biol 2007;103:178–188
   PubMed Web of Science ®Google Scholar
• Capellino S, Straub RH, Cutolo M. Aromatase and regulation of the estrogen-to-androgen ratio in synovial tissue inflammation: common pathway in both sexes. Ann N Y Acad Sci 2014;1317:24--31
   Google Scholar
• Valtysdottir ST, Wide L, Hallgren R. Mental wellbeing and quality of sexual life in women with primary Sjögren's syndrome are related to circulating dehydroepiandrosterone sulphate. Ann Rheum Dis 2003;62:875–879
   PubMed Web of Science ®Google Scholar
• Hartkamp A, Geenen R, Kruize AA, Bossema ER, Godaert GL, Bootsma H, et al. Serum dehydroepiandrosterone sulphate levels and laboratory and clinical parameters indicating expression of disease are not associated with fatigue, well-being and functioning in patients with primary Sjögren's syndrome. Clin Exp Rheumatol 2011;29:318–321
   Google Scholar
• Forsblad-d'Elia H, Carlsten H, Labrie F, Konttinen YT, Ohlsson C. Low serum levels of sex steroids are associated with disease characteristics in primary Sjogren's syndrome: supplementation with dehydroepiandrosterone restores the concentrations. J Clin Endocrinol Metab 2009;94:2044–2051
   PubMed Web of Science ®Google Scholar
• Genazzani AR, Stomati M, Valentino V, Pluchino N, Pot E, Casarosa E, et al. Effect of 1-year, low-dose DHEA therapy on climacteric symptoms and female sexuality. Climacteric 2011;14:661–668
   PubMed Web of Science ®Google Scholar
• Porola P, Straub RH, Virkki LM, Konttinen YT, Nordström DC. Failure of oral DHEA treatment to increase local salivary androgen outputs of female patients with Sjögren's syndrome. Scand J Rheumatol 2011;40:387–390
   PubMed Web of Science ®Google Scholar
• Pillemer SR, Brennan MT, Sankar V, Leakan RA, Smith JA, Grisius M, et al. Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjögren's syndrome. Arthritis Rheum 2004;51:601–604
   PubMedGoogle Scholar
• Hartkamp A, Geenen R, Godaert GL, Bootsma H, Kruize AA, Bijlsma JW, et al. Effect of dehydroepiandrosterone administration on fatigue, well-being, and functioning in women with primary Sjögren syndrome: a randomised controlled trial. Ann Rheum Dis 2008;67:91–97
   PubMed Web of Science ®Google Scholar
• Sullivan DA. Possible mechanisms involved in the reduced tear secretion in Sjögren’s syndrome. In: Homma M, Sugai S, Tojo T, Miyasaka N, Akizuki M, editors. Sjögren's syndrome. State of the Art. Amsterdam: Kugler Press; 1994. pp 13–19
   Google Scholar
• Zoukhri D. Effect of inflammation on lachrymal gland function. Exp Eye Res 2006;82:885–898
   PubMed Web of Science ®Google Scholar
• Dawson L, Tobin A, Smith P, Gordon T. Antimuscarinic antibodies in Sjogren’s syndrome: where are we, and where are we going? Arthritis Rheum 2005;52:2984–2995
   PubMed Web of Science ®Google Scholar
• Dawson LJ, Stanbury J, Venn N, Hasdimir B, Rogers SN, Smith PM. Antimuscarinic antibodies in primary Sjogren’s syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells. Arthritis Rheum 2006;54:1165–1173
   PubMed Web of Science ®Google Scholar
• Shimazaky J, Goto E, Masafumi O, Shimmura S, Tsubota K. Meibomian gland dysfunction in patients with Sjögren syndrome. Ophthalmology 1998;105:1485–1488
   Google Scholar
• Goto E, Matsumoto Y, Kamoi M, Endo K, Ishida R, Dogru M, et al. Tear evaporation rates in Sjögren syndrome and non-Sjögren dry eye patients. Am J Ophthalmol 2007;144:81–85
   Web of Science ®Google Scholar
• Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554–558
   PubMed Web of Science ®Google Scholar
• Vitali C, Bootsma H, Bowman SJ, Dorner T, Gottenberg JE, Mariette X, et al. Classification criteria for Sjogren's syndrome: we actually need to definitively resolve the long debate on the issue. Ann Rheum Dis 2013;72:476–478
   PubMed Web of Science ®Google Scholar
• Versura P, Frigato M, Mulé R, Malavolta N, Campos EC. A proposal of new ocular items in Sjögren's syndrome classification criteria. Clin Exp Rheumatol 2006;24:567–572
   PubMed Web of Science ®Google Scholar
• Versura P, Frigato M, Cellini M, Mulè R, Malavolta N, Campos EC. Diagnostic performance of tear function tests in Sjogren's syndrome patients. Eye (Lond) 2007;21:229–237
   PubMed Web of Science ®Google Scholar
• Baldini C, Talarico R, Tzioufas AG, Bombardieri S. Classification criteria for Sjogren's syndrome: a critical review. J Autoimmun 2012;39:9–14
   PubMed Web of Science ®Google Scholar
• Schaumberg DA, Nichols JJ, Papas EB, Tong L, Uchino M, Nichols KK. The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD. Invest Ophthalmol Vis Sci 2011;52:1994–2005
   PubMed Web of Science ®Google Scholar
• Schirra F, Richards SM, Liu M, Suzuki T, Yamagami H, Sullivan DA. Androgen regulation of lipogenic pathways in the mouse meibomian gland. Exp Eye Res 2006;83:291–296
   PubMed Web of Science ®Google Scholar
• Schirra F, Richards SM, Sullivan DA. Androgen influence on cholesterogenic enzyme mRNA levels in the mouse meibomian gland. Curr Eye Res 2007;32:393–398
   PubMed Web of Science ®Google Scholar
• Steagall RJ, Yamagami H, Wickham LA, Sullivan DA. Androgen control of gene expression in the rabbit meibomian gland. Adv Exp Med Biol 2002;506:465–476
   PubMed Web of Science ®Google Scholar
• Richards SM, Yamagami H, Schirra F, Suzuki T, Jensen RV, Sullivan DA. Sex-related effect on gene expression in the mouse meibomian gland. Curr Eye Res 2006;31:119–128
   PubMed Web of Science ®Google Scholar
• Schirra F, Suzuki T, Richards SM, Jensen RV, Liu M, Lombardi MJ, et al. Androgen control of gene expression in the mouse meibomian gland. Invest Ophthalmol Vis Sci 2005;46:3666–3675
   PubMed Web of Science ®Google Scholar
• Sullivan DA, Yamagami H, Liu M, Steagali RJ, Schirra F, Suzuki T, et al. Sex steroids, the meibomian gland and evaporative dry eye. Adv Exp Med Biol 2002;506:389–399
   Google Scholar
• Sullivan BD, Evans JE, Dana MR, Sullivan DA. Influence of aging on the polar and neutral lipid profiles in human meibomian gland secretions. Arch Ophthalmol 2006;124:1286–1292
   PubMedGoogle Scholar
• Sullivan BD, Evans JE, Cermak JM, Krenzer KL, Dana MR, Sullivan DA. Complete androgen insensitivity syndrome: effect on human meibomian gland secretions. Arch Ophthalmol 2002;120:1689–1699
   PubMedGoogle Scholar
• Sullivan BD, Evans JE, Krenzer KL, Dana MR, Sullivan DA. Impact of antiandrogen treatment on the fatty acid profile of neutral lipids in human meibomian gland secretions. J Clin Endocrinol Metab 2000;85:4866–4873
   PubMed Web of Science ®Google Scholar
• Suzuki T, Schirra F, Richards SM, Jensen RV, Sullivan DA. Estrogen and progesterone control of gene expression in the mouse meibomian gland. Invest Ophthalmol Vis Sci 2008;49:1797–1808
   PubMed Web of Science ®Google Scholar
• Butler L, Santoro N. The reproductive endocrinology of the menopausal transition. Steroids 2011;76:627–635
   PubMed Web of Science ®Google Scholar
• Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 2002;87:589–598
   PubMed Web of Science ®Google Scholar
• Santoro N, Randolph JF Jr. Reproductive hormones and the menopause transition. Obstet Gynecol Clin North Am 2011;38:455–466
   PubMed Web of Science ®Google Scholar
• Hale GE, Robertson DM, Burger HG. The perimenopausal woman: endocrinology and management. Steroid Biochem Mol Biol 2014;142:121–131
   PubMed Web of Science ®Google Scholar
• Labrie F, Martel C, Balser J. Wide distribution of the serum dehydroepiandrosterone and sex steroid levels in postmenopausal women: role of the ovary? Menopause 2011;18:30–43
   PubMed Web of Science ®Google Scholar
• Rannevik G, Jeppsson S, Johnell O, Bjerre B, Laurell-Borulf Y, Svanberg L. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas 1995;21:103–113
   PubMed Web of Science ®Google Scholar
• Yasui T, Matsui S, Tani A, Kunimi K, Yamamoto S, Irahara M. Androgen in postmenopausal women. J Med Invest 2012;59:12–27
   PubMedGoogle Scholar
• Burger HG, Dudley EC, Cui J, Dennerstein L, Hopper JC. A prospective longitudinal study of serum testosterone dehydroepiandrosterone sulfate and sex hormone binding globulin levels through the menopause transition. J Clin Endocrin Metab 2000;85:2832–2838
   PubMed Web of Science ®Google Scholar
• Marjoribanks J, Farquhar C, Roberts H, Lethaby A. Long term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev 2012;7:CD004143
   PubMed Web of Science ®Google Scholar
• Hodis HN, Mack WJ. Hormone replacement therapy and the association with coronary heart disease and overall mortality: clinical application of the timing hypothesis. J Steroid Biochem Mol Biol 2014;142:68--75
   Google Scholar
• Clarkson TB, Meléndez GC, Appt SE. Timing hypothesis for postmenopausal hormone therapy: its origin, current status, and future. Menopause 2013;20:342–353
   PubMed Web of Science ®Google Scholar
• Nagler RM, Pollack S. Sjogren’s syndrome induced by estrogen therapy. Semin Arthritis Rheum 2000;30:209–214
   Google Scholar
• Erdem U, Ozdegirmenci O, Sobaci E, Goktolga U, Dagli S. Dry eye in postmenopausal women using hormone replacement therapy. Maturitas 2007;56:257–262
   PubMed Web of Science ®Google Scholar
• Uncu G, Avici R, Uncu Y, Kaymaz C, Develioglu O. The effects of different hormone replacement therapy regiments on tear function, intraocular pressure and lens opacity. Gynecol Endocrinol 2006;22:501–505
   PubMed Web of Science ®Google Scholar
• Jensen AA, Higginbotham EJ, Guzinski GM, Davis IL, Ellish NJ. A survey of ocular complaints in postmenopausal women. J Assoc Acad Minor Phys 2000;11:44–49
   PubMedGoogle Scholar
• Okon A, Jurowski P, Gos R. The influence of the hormonal replacement therapy on conjunctival epithelium morphology among peri- and postmenopausal women. Klinika Oczna 2001;103:183–186
   Google Scholar
• Rocha EM, Mantelli F, Nominato LF, Bonini S. Hormones and dry eye syndrome: an update on what we do and don’t know. Curr Opin Ophthalmol 2013;24:348–355
   PubMed Web of Science ®Google Scholar
• Davis SR, Worsley R. Androgen treatment of postmenopausal women. J Steroid Biochem Mol Biol 2014;142:107--114
   Google Scholar
• Labrie F. DHEA, important source of sex steroids in men and even more in women. Prog Brain Res 2010;182:97–148
   PubMed Web of Science ®Google Scholar
• Davis SR, Panjari M, Stanczyk FZ. Clinical review: DHEA replacement for postmenopausal women. J Clin Endocrinol Metab 2011;96:1642–1653
   PubMed Web of Science ®Google Scholar
• Versura P, Campos EC. Menopause and dry eye. A possible relationship. Gynecol Endocrinol 2005;20:289–298
   PubMed Web of Science ®Google Scholar
• Sator MO, Joura EA, Golaszewski T, Gruber D, Frigo P, Metka M, et al. Treatment of menopausal keratoconjunctivitis sicca with topical oestradiol. Br J Obstetr Gynaecol 1998;105:100–102
   PubMedGoogle Scholar
• Lubkin V. An evaluation of the safety and efficacy of 0.1% & 0.25% 17β-estradiol in postmenopausal women with dry eye syndrome. USPN 6,096,733, Issued Aug. 2000
   Google Scholar
• Nathanson JA, McKee M. Identification of an extensive system of nitric oxide-producing cells in the ciliary muscle and outflow pathway of the human eye. Invest Ophthalmol Vis Sci 1995;36:1765–1772
   PubMed Web of Science ®Google Scholar
• Worda C, Nepp J, Huber JC, Sator MO. Treatment of keratoconjunctivitis sicca with topical androgen. Maturitas 2001;37:209–212
   PubMed Web of Science ®Google Scholar
• Safety and Efficacy of testosterone 0.03% Ophthalmic Solution Compared to Vehicle for the Treatment of MGD (ClinicalTrials.gov ID NCT00755183)
   Google Scholar
• Nanavaty MA, Long M, Malhotra R. Transdermal androgen patches in evaporative dry eye syndrome with androgen deficiency: a pilot study. Br J Ophthalmol 2014;98:567–569
   PubMed Web of Science ®Google Scholar
• Schiffman RM, Bradford R, Bunnell B, Lai F, Bernstein P, Whitcup SW. A multi–center, double–masked, randomized, vehicle–controlled, parallel group study to evaluate the safety and efficacy of testosterone ophthalmic solution in patients with meibomian gland dysfunction. Invest Ophthalmol Vis Sci 2006;47:E-Abstract 5608
   Google Scholar
• Schechter JE, Warren DW, Mircheff AK. A lachrymal gland is a lachrymal gland, but rodent's and rabbit's are not human. Ocul Surf 2010;8:111–134
   PubMed Web of Science ®Google Scholar
• Mehta R, Jain RK, Badve S. Personalized medicine: the road ahead. Clin Breast Cancer 2011;11:20–26
   PubMed Web of Science ®Google Scholar
• Manson JE. The role of personalized medicine in identifying appropriate candidates for menopausal estrogen therapy. Metabolism 2013;62:S15–S19
   PubMedGoogle Scholar
• Novack GD. Personalized medicine and the ocular surface. Ocular Surf 2010;8:157–159
   Google Scholar
• Aragona P, Rolando M. Towards a dynamic customised therapy for ocular surface dysfunctions. Br J Ophthalmol 2013;97:955–960
   Google Scholar